Structure Info
- Chemspace ID
- CSSS00000054742 (In-Stock Screening Compounds)
- CAS
- 322-79-2
- MFCD
- MFCD00866793
- IUPAC Name
- 2-(acetyloxy)-4-(trifluoromethyl)benzoic acid
- Mol formula
- C10H7F3O4
- Mol weight
- 248 Da
- Catalog Number(s)
- 30274, 38332, 66043, 151838, 322-79-2, A626746, AA007GWY, AC034399, ACDS-034180, ACM322792, AD48414, ADB48460001, AG-19716, AG007GZQ, AL48414, AOS007GZQ, AP322792, APS322792, AR007HOQ, AS-63983, B1461, BB4LS-BD42634, BBV-356733709, BD42634, CSC000054742, D480545, EN300-18567716, F828198, FT28493, HY-B0531, I589, J55536, JH671521, LAN-B14840, LN00189377, LP050376, LQT-B14874, M14050, R007893, S3200, SAB-029683, SC-16156, T0705, T3601, T72290, T72290-0.25G, T793600, W-106849
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.12
- Heavy atoms count
- 17
- Rotatable bond count
- 4
- Number of rings
- 1
- Carbon bond saturation, Fsp3
- 0.2
- Polar surface area (Å)
- 64
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSS00000054742
Items Overall 16 items from 3 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| MedChemExpress | 10 days | United States To: | 99 | 5 mg | 50 | |
| MedChemExpress | 10 days | United States To: | 99 | 10 mg | 80 | |
| MedChemExpress | 10 days | United States To: | 99 | 50 mg | 250 | |
| MedChemExpress | 10 days | United States To: | 99 | 100 mg | 400 | |
| MedChemExpress | 10 days | United States To: | 99 | 10mM/1mL | 55 | |
Description: Names: Triflusal; Product Description: Triflusal irreversibly inhibits the production of thromboxane-B2 in platelets by acetylating cycloxygenase-1.Target: COXTriflusal at 10 mM, 100 mM and 1 M decreases LDH efflux in rat brain slices after anoxia/reoxygenation by 24%, 35% and 49% respectively. Triflusal also reduces inducible NO synthase activity by 18%, 21% and 30% Triflusal (10 mg/kg i.v.) reduces platelet deposition on subendothelium-induced primary thrombus by about 68% in rabbits. Triflusal (10 mg/kg i.v.) reduces platelet deposition on a fresh thrombus formed over tunica media by about 48% in rabbits. Triflusal (40 mg/kg p.o.) reduces platelet deposition on a primary thrombus triggered by subendothelium and tunica media by 53% in rabbits. Triflusal (40 mg/kg p.o.) significantly reduces Cox-2 mRNA levels and protein levels without influence Cox-1 mRNA levels on the vascular wall in rabbits Triflusal (600 mg/day for 5 days) results in an increase in NO production by neutrophils and an increase in endothelial nitric oxide synthase (eNOS) protein expression in neutrophils in healthy volunteers ; Target: COX; CAS: 322-79-2 | ||||||
| MedChemExpress EU | 10 days | Sweden To: | 99 | 5 mg | 53 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 10 mg | 68 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 25 mg | 100 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 50 mg | 132 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 100 mg | 173 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 500 mg | 316 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 10mM/1mL | 58 | |
Description: Names: Triflusal; Product Description: Triflusal irreversibly inhibits the production of thromboxane-B2 in platelets by acetylating cycloxygenase-1.Target: COXTriflusal at 10 mM, 100 mM and 1 M decreases LDH efflux in rat brain slices after anoxia/reoxygenation by 24%, 35% and 49% respectively. Triflusal also reduces inducible NO synthase activity by 18%, 21% and 30% Triflusal (10 mg/kg i.v.) reduces platelet deposition on subendothelium-induced primary thrombus by about 68% in rabbits. Triflusal (10 mg/kg i.v.) reduces platelet deposition on a fresh thrombus formed over tunica media by about 48% in rabbits. Triflusal (40 mg/kg p.o.) reduces platelet deposition on a primary thrombus triggered by subendothelium and tunica media by 53% in rabbits. Triflusal (40 mg/kg p.o.) significantly reduces Cox-2 mRNA levels and protein levels without influence Cox-1 mRNA levels on the vascular wall in rabbits Triflusal (600 mg/day for 5 days) results in an increase in NO production by neutrophils and an increase in endothelial nitric oxide synthase (eNOS) protein expression in neutrophils in healthy volunteers ; Target: COX; CAS: 322-79-2 | ||||||
| Apexbio Technology LLC | 10 days | United States To: | 99 | 5 mg | 55 | |
| Apexbio Technology LLC | 10 days | United States To: | 99 | 10 mg | 88 | |
| Apexbio Technology LLC | 10 days | United States To: | 99 | 25 mg | 209 | |
| Apexbio Technology LLC | 10 days | United States To: | 99 | 10mM (in 1mL DMSO) | 55 | |
Description: Name: Triflusal; COX inhibitor; Format: a solid; CAS: 322-79-2 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire